Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control
Authors:
Top Cited Papers
Open Access
- 15 March 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (12) , 1739-1746
Abstract
Background. Delayed treatment of candidemia has previously been shown to be an important determinant of patient outcome. However, septic shock attributed to Candida infection and its determinants of outcome have not been previously evaluated in a large patient population. Methods. A retrospective cohort study of hospitalized patients with septic shock and blood cultures positive for Candida species was conducted at Barnes-Jewish Hospital, a 1250-bed urban teaching hospital (January 2002–December 2010). Results. Two hundred twenty-four consecutive patients with septic shock and a positive blood culture for Candida species were identified. Death during hospitalization occurred among 155 (63.5%) patients. The hospital mortality rate for patients having adequate source control and antifungal therapy administered within 24 hours of the onset of shock was 52.8% (n = 142), compared to a mortality rate of 97.6% (n = 82) in patients who did not have these goals attained (P < .001). Multivariate logistic regression analysis demonstrated that delayed antifungal treatment (adjusted odds ratio [AOR], 33.75; 95% confidence interval [CI], 9.65–118.04; P = .005) and failure to achieve timely source control (AOR, 77.40; 95% CI, 21.52–278.38; P = .001) were independently associated with a greater risk of hospital mortality. Conclusions. The risk of death is exceptionally high among patients with septic shock attributed to Candida infection. Efforts aimed at timely source control and antifungal treatment are likely to be associated with improved clinical outcomes.Keywords
This publication has 36 references indexed in Scilit:
- Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic ShockChest, 2009
- Broad‐Spectrum Antimicrobials and the Treatment of Serious Bacterial Infections: Getting It Right Up FrontClinical Infectious Diseases, 2008
- Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis*Critical Care Medicine, 2003
- Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsisThe American Journal of Medicine, 2003
- The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): Role, methodology, and results*Critical Care Medicine, 2003
- Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 2001
- Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of careCritical Care Medicine, 2001
- Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumoniaIntensive Care Medicine, 2000
- The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU SettingChest, 2000
- Inadequate Antimicrobial Treatment of InfectionsChest, 1999